ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Ambulatory Health Care Facilities, Clinic/Center

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,384Medicare Part D Prescriptions Filled, Including Refills
$1.56M Total Retail Price of All Prescriptions
1,238 Patients Receiving at Least One Drug in Part D
82% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category
NAMENDA 1,473 1,409 138
DONEPEZIL HCL 875 839 151
LEVOTHYROXINE SODIUM 684 646 146
METOPROLOL TARTRATE 582 506 135
LISINOPRIL 567 463 153
AMLODIPINE BESYLATE 551 512 124
SIMVASTATIN 415 356 164
ALBUTEROL SULFATE 381 341 110
OLANZAPINE 366 301 64 A
METFORMIN HCL 351 310 122
FUROSEMIDE 346 305 87
HYDROCHLOROTHIAZIDE 315 283 91
RISPERIDONE 305 300* 48 A
METOPROLOL SUCCINATE 302 260 93
OMEPRAZOLE 299 277 89
AZITHROMYCIN 278 241 202
TRAMADOL HCL 243 223 80
POTASSIUM CHLORIDE 243 206 54
FAMOTIDINE* 239 194 39
QUETIAPINE FUMARATE 238 203 40 A
DIOVAN 235 230* 30
EXELON 235 188 30
LACTULOSE 234 155 53
GLIPIZIDE 233 218 64
CARBIDOPA-LEVODOPA 222 217* 32
LANTUS 220 203 41
WARFARIN SODIUM 210 205* 34
ZOLPIDEM TARTRATE 210 184 79
CITALOPRAM HBR 205 189 41
ESCITALOPRAM OXALATE 205 175 45
LOSARTAN POTASSIUM 188 168 52
CIPROFLOXACIN HCL 187 163 129
LORAZEPAM 183 160 53 B
JANUVIA 176 158 32
TAMSULOSIN HCL 172 147 41
ALPRAZOLAM 171 131 63 B
RANITIDINE HCL 170 154 36
ATORVASTATIN CALCIUM 167 144 61
NEXIUM 159 143 70
CLONIDINE HCL 159 137 47
LEVOFLOXACIN 156 135 126
NOVOLIN R 154 149* 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 139 115 96
PANTOPRAZOLE SODIUM 137 132* 40
MIRTAZAPINE 130 116 27
IBUPROFEN 128 94 64
NAPROXEN 127 107 78
MONTELUKAST SODIUM 125 110 37
CLOPIDOGREL 125 120* 47
HYDROXYZINE HCL 125 120* 30 R
ENALAPRIL MALEATE 120 106 44
MELOXICAM 118 104 46
CYMBALTA 115 73 14
MUPIROCIN* 114 98 66
CLOTRIMAZOLE-BETAMETHASONE 114 84 51
GLYBURIDE-METFORMIN HCL 112 86 47 R
LEVETIRACETAM 110 72 18
KETOCONAZOLE 108 86 37
PRAVASTATIN SODIUM 102 68 52
TRAZODONE HCL 101 85 22
LEVEMIR 96 82 24
BACLOFEN 96 59 16
ALLOPURINOL 95 90* 15
LOSARTAN-HYDROCHLOROTHIAZIDE 93 81 34
CRESTOR 91 80 32
ISOSORBIDE MONONITRATE ER 91 86* 20
NOVOLOG 84 70 18
FLUTICASONE PROPIONATE 82 70 37
LEVEMIR FLEXPEN 81 61 21
PHENYTOIN 75 <11 <11
NIFEDIPINE ER 74 74 16
ATENOLOL 73 46 21
SERTRALINE HCL 73 68* 18
POLYETHYLENE GLYCOL 3350 72 59 33
HYDROCODONE-ACETAMINOPHEN 71 57 36 S3
LAMOTRIGINE 70 <11 <11
HYDRALAZINE HCL 69 52 15
KLOR-CON M20 69 64* 17
LANTUS SOLOSTAR 68 57 21
FINASTERIDE 68 68 12
ABILIFY 67 <11 <11 A
PROMETHAZINE HCL 66 61* 44 R
LATANOPROST 66 66 15
NAMENDA XR 65 65 13
CARVEDILOL 65 60* 18
NYSTATIN 62 57* 46
LYRICA 61 37 18
CELEBREX 61 56* 36
DIGOXIN 61 56* 14
LOVASTATIN 61 48 30
AZILECT 61 <11 <11
IPRATROPIUM BROMIDE 60 55* 17
ALENDRONATE SODIUM 59 59 16
NITROFURANTOIN* 58 53* 37
NITROGLYCERIN PATCH 57 <11 <11
DOXYCYCLINE HYCLATE 57 52* 49
PAROXETINE HCL 57 52* 13
GLYBURIDE 56 51* 21 R
MECLIZINE HCL 56 51* 28
ARICEPT 55 <11 <11
MEGESTROL ACETATE 55 50* 26 R
AMIODARONE HCL 55 <11 <11
RANEXA 53 <11 <11
PHENYTOIN SODIUM EXTENDED 53 40 11
DILTIAZEM HCL 53 <11 <11
KLOR-CON M10 52 52 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 47* 26
RENVELA 51 <11 <11
ROPINIROLE HCL 51 46* 12
PIOGLITAZONE HCL 50 <11 <11 R
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.